BioCentury
ARTICLE | Clinical News

Ameluz regulatory update

December 22, 2014 8:00 AM UTC

Swissmedic accepted for review an MAA for Ameluz from Louis Widmer S.A. (Schlieren, Switzerland) to treat actinic keratosis. The photodynamic therapy comprising nanoemulsion BF-200 with 5-aminolevuli...